Lupin expands US women’s health portfolio with $150m acquisition of Symbiomix Therapeutics

Lupin Limited, a Mumbai-based generics pharmaceutical company, has strategically broadened its foothold in the women’s health sector by acquiring Symbiomix Therapeutics. The acquisition, valued at ... Read More